Clinical & Experimental Metastasis (Record no. 2054)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03020nas a22003855i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 1573-7276 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260610082458.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 150723s||||||||ne uu poo|||||| b|EN |d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1573-7276 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/10585.1573-7276 |
| Source of number or code | doi |
| 210 10 - ABBREVIATED TITLE | |
| Abbreviated title | Clin Exp Metastasis |
| 245 10 - TITLE STATEMENT | |
| Title | Clinical & Experimental Metastasis |
| Medium | [electronic resource] : |
| Remainder of title | Official Journal of the Metastasis Research Society / |
| Statement of responsibility, etc. | edited by Jonathan Sleeman, Jörg Haier. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Dordrecht : |
| Name of producer, publisher, distributor, manufacturer | Springer Netherlands : |
| -- | Imprint: Springer. |
| 300 ## - online resource | |
| Other physical details | online resource. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Clinical & Experimental Metastasis is an international, multidisciplinary journal devoted to the rapid publication of major fundamental advances in both basic and applied metastasis research. Clinical & Experimental Metastasis publishes Original Articles, Reviews, Short Communications, Commentaries and Letters to the Editor. The Journal's scope encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It covers such areas as molecular biology, pharmacology, tumor biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the Journal's core subject of metastasis formation, prevention and treatment. While the emphasis is on speed of publication, with papers normally published within 2 weeks of acceptance, the Editors rigorously maintain refereeing standards to ensure only the highest quality research is selected for publication. Case studies are published only in exceptional circumstances and are better suited to journals that focus on case reports. Correlative clinical studies with small numbers of patients need to contain experimental validation of the findings. Experimental and laboratory-based research needs to provide a significant advance in knowledge, and should contain mechanistic functional insights. Validation of findings made with cell lines in experimental animal models is generally expected. Except in exceptional cases, verification of experimental data in at least two independent cell lines is generally required in order to exclude cell line-specific effects. . |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medicine—Research. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biology—Research. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oncology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hematology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer—Treatment. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer Biology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomedical Research. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oncology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hematology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cancer Therapy. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sleeman, Jonathan. |
| Relator term | editor. |
| Relationship | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Haier, Jörg. |
| Relator term | editor. |
| Relationship | edt |
| -- | http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed version: |
| International Standard Serial Number | 0262-0898 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/10585.1573-7276">https://doi.org/10.1007/10585.1573-7276</a> |
| Public note | Hybrid |
No items available.